πŸ‡ΊπŸ‡Έ FDA
Patent

US 9144604

Vaccine for Shigella

granted A61KA61K2039/6037A61K2039/6068

Quick answer

US patent 9144604 (Vaccine for Shigella) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/6037, A61K2039/6068, A61K2039/6081, A61K39/02